Emerg Infect Dis. 2017 Dec;23(13):S101-7. doi: 10.3201/eid2313.170603.
Cervical cancer incidence and mortality rates are high, particularly in developing countries. Most cervical cancers can be prevented by human papillomavirus (HPV) vaccination, screening, and timely treatment. The US Centers for Disease Control and Prevention (CDC) provides global technical assistance for implementation and evaluation of HPV vaccination pilot projects and programs and laboratory-related HPV activities to assess HPV vaccines. CDC collaborates with global partners to develop global cervical cancer screening recommendations and manuals, implement screening, create standardized evaluation tools, and provide expertise to monitor outcomes. CDC also trains epidemiologists in cancer prevention through its Field Epidemiology Training Program and is working to improve cancer surveillance by supporting efforts of the World Health Organization in developing cancer registry hubs and assisting countries in estimating costs for developing population-based cancer registries. These activities contribute to the Global Health Security Agenda action packages to improve immunization, surveillance, and the public health workforce globally.
宫颈癌的发病率和死亡率都很高，尤其是在发展中国家。大多数宫颈癌可以通过人乳头瘤病毒（HPV）疫苗接种、筛查和及时治疗来预防。美国疾病控制与预防中心（CDC）为实施和评估 HPV 疫苗试点项目和计划以及与实验室相关的 HPV 活动提供全球技术援助，以评估 HPV 疫苗。CDC 与全球合作伙伴合作制定全球宫颈癌筛查建议和手册，实施筛查，创建标准化评估工具，并提供专业知识以监测结果。CDC 还通过其现场流行病学培训计划培训癌症预防流行病学家，并通过支持世界卫生组织建立癌症登记中心枢纽和协助各国估算建立基于人群的癌症登记处的费用，努力改善癌症监测。这些活动有助于全球卫生安全议程行动方案，以改善全球的免疫、监测和公共卫生劳动力。
